دورية أكاديمية
Nusinersen modulates proteomics profiles of cerebrospinal fluid in spinal muscular atrophy type 1 patients
| العنوان: | Nusinersen modulates proteomics profiles of cerebrospinal fluid in spinal muscular atrophy type 1 patients |
|---|---|
| المؤلفون: | Bianchi L., Sframeli M., Vantaggiato L., Vita G. L., Ciranni A., Polito F., Oteri R., Gitto E., Di Giuseppe F., Angelucci S., Versaci A., Messina S., Vita G., Bini L., Aguennouz M. |
| المساهمون: | Bianchi, L., Sframeli, M., Vantaggiato, L., Vita, G. L., Ciranni, A., Polito, F., Oteri, R., Gitto, E., Di Giuseppe, F., Angelucci, S., Versaci, A., Messina, S., Vita, G., Bini, L., Aguennouz, M. |
| سنة النشر: | 2021 |
| المجموعة: | Università degli Studi di Siena: USiena air |
| مصطلحات موضوعية: | Apolipoprotein A1, Apolipoprotein E, ASO, Carbonyl group, Haptoglobin, Neuromuscular disease, Nusinersen, Oxidized protein, Spinal muscular atrophy type 1, Survival motor neuron (SMN), Transthyretin |
| الوصف: | Spinal muscular atrophy (SMA) type 1 is a severe infantile autosomal‐recessive neuromuscular disorder caused by a survival motor neuron 1 gene (SMN1) mutation and characterized by progressive muscle weakness. Without supportive care, SMA type 1 is rapidly fatal. The antisense oligonucleotide nusinersen has recently improved the natural course of this disease. Here, we investigated, with a functional proteomic approach, cerebrospinal fluid (CSF) protein profiles from SMA type 1 patients who underwent nusinersen administration to clarify the biochemical response to the treatment and to monitor disease progression based on therapy. Six months after starting treatment (12 mg/5 mL × four doses of loading regimen administered at days 0, 14, 28, and 63), we observed a generalized reversion trend of the CSF protein pattern from our patient cohort to that of control donors. Notably, a marked up‐regulation of apolipoprotein A1 and apolipoprotein E and a consistent variation in transthyretin proteoform occurrence were detected. Since these multifunctional proteins are critically active in biomolecular processes aberrant in SMA, i.e., synaptogenesis and neurite growth, neuronal survival and plasticity, inflammation, and oxidative stress control, their nusinersen induced modulation may support SMN improved-expression effects. Hence, these lipoproteins and transthyretin could represent valuable biomarkers to assess patient responsiveness and disease progression. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | ELETTRONICO |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000650376400001; volume:22; issue:9; numberofpages:29; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/11365/1198063Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104421614; https://www.mdpi.com/1422-0067/22/9/4329Test |
| DOI: | 10.3390/ijms22094329 |
| الإتاحة: | https://doi.org/10.3390/ijms22094329Test http://hdl.handle.net/11365/1198063Test https://www.mdpi.com/1422-0067/22/9/4329Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.5AB39E1E |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/ijms22094329 |
|---|